| # | Drug | Count |
|---|---|---|
| 0 | RESMETIROM | 13 |
| 1 | ASPIRIN | 8 |
| 2 | ASPIRIN 325 MG | 8 |
| 3 | ASPIRIN 81 MG | 8 |
| 4 | METFORMIN | 8 |
| 5 | LEVOTHYROXINE SODIUM | 7 |
| 6 | METHOTREXATE SODIUM | 7 |
| 7 | RAMIPRIL | 7 |
| 8 | FOLIC ACID | 6 |
| 9 | LEVOTHYROXINE SODIUM ANHYDROUS | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PITAVASTATIN MAGNESIUM | 1 | 0.0169 |
| 1 | BULEVIRTIDE | 1 | 0.0104 |
| 2 | RESMETIROM | 13 | 0.0057 |
| 3 | FLUVOXAMINE MALEATE | 1 | 0.0004 |
| 4 | AVELUMAB | 1 | 0.0002 |
| 5 | POTASSIUM CITRATE | 1 | 0.0002 |
| 6 | UBROGEPANT | 1 | 0.0002 |
| 7 | ATOGEPANT | 1 | 0.0001 |
| 8 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 9 | CLADRIBINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 13 | 0.0057 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |
| 3 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 7 | 0.0001 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 7 | Progesterone [EPC] | 1 | 0.0000 |
| 8 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |